The Urology Group
Press / In The News /
September 20, 2017

NKY Tribune - Immunotherapy Treatment

Drs. Gary Kirsh and Brooke Edwards share hopeful news for African Americans facing advanced prostate cancer​. An FDA-approved immunotheraphy has been shown to provide additional overall survival benefit of 9.3 months for African-American men with advanced prostate cancer. 

Click here to read full article. 

 

Get the latest news about The Urology Group:

 

Patient Help Center
Our patient portal is undergoing maintenance and is currently not available. We apologize for the inconvenience.

PATIENT FORMSPAY ONLINEFIND AN OFFICE

CALENDAR OF EVENTS IN THE NEWS BLOG PRESS RELEASES